Old Web
English
Sign In
Acemap
>
authorDetail
>
Christopher Lee
Christopher Lee
Boehringer Ingelheim
Type 2 diabetes
Medicine
Empagliflozin
Linagliptin
Randomized controlled trial
5
Papers
39
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Linagliptin as add‐on to empagliflozin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two‐part, randomized, placebo‐controlled trial
2019
Diabetes, Obesity and Metabolism
Kohei Kaku
Masakazu Haneda
Yuko Tanaka
Ganghyuck Lee
Kosuke Shiki
Yuki Miyamoto
Fernando Solimando
Jisoo Lee
Christopher Lee
Jyothis T. George
Show All
Source
Cite
Save
Citations (8)
Machine Learning to Identify Predictors of Glycemic Control in Type 2 Diabetes: An Analysis of Target HbA1c Reduction Using Empagliflozin/Linagliptin Data
2019
Pharmaceutical medicine
Angelo Del Parigi
Wenbo Tang
Dacheng Liu
Christopher Lee
Richard E. Pratley
Show All
Source
Cite
Save
Citations (1)
1